Avalyn Pharma (AVLN) director receives grant of 26,978 stock options at $18
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Avalyn Pharma Inc. director Heather D. Turner received a compensation grant of stock options covering 26,978 shares of common stock. The options have an exercise price of $18.00 per share and expire on April 28, 2036.
According to the vesting terms, 25% of the shares vest and become exercisable on September 12, 2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to her continued service. Following this grant, Turner holds stock options for 26,978 underlying shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Turner Heather D
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 26,978 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 26,978 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 26,978 options
Exercise price: $18.00 per share
Underlying shares: 26,978 shares
+4 more
7 metrics
Options granted
26,978 options
Stock Option (Right to Buy) grant to director
Exercise price
$18.00 per share
Strike price for the stock options
Underlying shares
26,978 shares
Common stock underlying granted options
Post-grant option holdings
26,978 options
Total options held following transaction
Initial vesting date
September 12, 2025
25% of options vest on this date
Remaining vesting schedule
36 monthly installments
Remaining 75% vests over 36 months
Option expiration
April 28, 2036
Expiration date of the stock options
Key Terms
Stock Option (Right to Buy), exercise price, vesting, expiration date, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 18.0000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"25% of the shares underlying this option vest and become exercisable"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-04-28"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: Common Stock"
FAQ
What insider transaction did Heather D. Turner report for AVLN?
Heather D. Turner reported receiving a grant of stock options for 26,978 shares of Avalyn Pharma common stock. These options are a compensation award, not an open-market purchase, and give her the right to buy shares at a fixed exercise price.
What is the exercise price of Heather D. Turner’s Avalyn Pharma options?
The granted stock options have an exercise price of $18.00 per share. This means Turner can later buy Avalyn Pharma common stock at $18.00, regardless of the future market price, once the options have vested.
How do Heather D. Turner’s AVLN stock options vest over time?
Twenty-five percent of the options vest on September 12, 2025. The remaining 75% vest in 36 equal monthly installments afterward, contingent on Turner’s continued service, creating a multi-year incentive structure aligned with ongoing board participation.
When do Heather D. Turner’s Avalyn Pharma options expire?
The stock options granted to Heather D. Turner expire on April 28, 2036. After that date, any unexercised options will lapse, so the potential right to buy Avalyn Pharma shares at $18.00 ends on that expiration date.